Epix and Mallinckrodt link with Siemens:
This article was originally published in Clinica
Executive Summary
Siemens Medical Systems, Epix Medical and Mallinckrodt are to collaborate on developing contrast-based cardiovascular magnetic resonance imaging (MRI) technologies. The collaboration will combine AngioMark-enhanced MRI with advanced imaging and three-dimensional computerised visualisation technologies. AngioMark, Epix and Mallinckrodt's intravascular contrast agent, is currently in Phase II trials for detecting aorto-iliac occlusive disease.